BioNTech SE (BNTX) Evaluates Vaccine Manufacturing Options in Rwanda and Senegal to Improve Long-Term Vaccine Supply

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. TSLA
6. USO
7. AMD
8. META
9. AMC
10. COHR

Go back to BioNTech SE (BNTX) Evaluates Vaccine Manufacturing Options in Rwanda and Senegal to Improve Long-Term Vaccine Supply
(NASDAQ: BNTX) Delayed: 98.00 +1.94 (2.02%)
Previous Close $96.06    52 Week High $ 
Open $97.25    52 Week Low $ 
Day High $98.98    P/E N/A 
Day Low $96.61    EPS $ 
Volume 800,850